GlassScriptPhysician profile
Ryan Allen Roy
NPI 1205873536
$624.36
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.25 · 2020: $49.76 · 2021: $61.58 · 2022: $141 · 2023: $99.94 · 2024: $21.30 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $117.38 | 2019-2025 | Evenity |
| Hologic Sales and Service, LLC | $62.85 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Astellas Pharma US INC | $61.17 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $59.94 | 2021-2023 | |
| Coopersurgical, INC. | $39.01 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Abbvie INC. | $37.87 | 2022 | |
| Pfizer INC. | $35.61 | 2021-2023 | |
| Exeltis, USA INC. | $34.97 | 2022-2025 | Slynd |
| Medtronic, INC. | $20.56 | 2022 | |
| Sumitomo Pharma America, INC. | $18.94 | 2025 | Myfembree |
| Urovant Sciences INC | $18.18 | 2022 | |
| Duchesnay USA Incorporated | $17.33 | 2019 | |
| Lilly USA, LLC | $16.97 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $16.41 | 2025 | Shingrix |
| Avion Pharmaceuticals | $14.94 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $13.68 | 2022 | |
| Organon LLC | $13.46 | 2022 | |
| Merck Sharp & Dohme LLC | $13.07 | 2022 | |
| Minerva Surgical, INC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.